Failure-to-Warn Product Liability Complaint - Arizona

COMPLAINT FOR FAILURE TO WARN (STRICT LIABILITY AND NEGLIGENCE) — ARIZONA

1. CAPTION

IN THE SUPERIOR COURT OF THE STATE OF ARIZONA

IN AND FOR THE COUNTY OF [____]

Case No.: [____]

COMPLAINT

(Tier 3 — Jury Trial Demanded)

2. INTRODUCTION

2.1. Plaintiff [PLAINTIFF NAME] ("Plaintiff"), by and through undersigned counsel, brings this action against Defendants for personal injuries proximately caused by Defendants' failure to provide adequate warnings and instructions regarding the foreseeable risks of harm associated with [PRODUCT TYPE] (the "Product"), which Defendants designed, manufactured, marketed, distributed, and/or sold.

3. PARTIES

3.1. Plaintiff [PLAINTIFF NAME] is, and at all relevant times was, an individual residing in [COUNTY] County, Arizona.

3.2. Defendant [MANUFACTURER NAME] ("Manufacturer") is a "manufacturer" within the meaning of A.R.S. § 12-681, organized under the laws of [STATE] with its principal place of business in [CITY, STATE], engaged in designing, manufacturing, testing, labeling, marketing, and selling the Product, and conducting business in Arizona.

3.3. Defendant [DISTRIBUTOR/SELLER NAME] ("Seller") is a "seller" within the meaning of A.R.S. § 12-681, engaged in the business of distributing and/or selling the Product in Arizona.

3.4. The true names and capacities of the fictitiously named Defendants are unknown to Plaintiff, who will amend to substitute true names when ascertained.

4. JURISDICTION AND VENUE

4.1. This Court has subject-matter jurisdiction under Article VI, § 14 of the Arizona Constitution.

4.2. This Court has personal jurisdiction over each Defendant under Rule 4.2, Ariz. R. Civ. P., because each Defendant transacts business in Arizona and/or placed the Product into the stream of commerce with the expectation it would be used in Arizona.

4.3. Venue is proper in this County under A.R.S. § 12-401 because [the injury occurred / the Product was sold / a Defendant resides or transacts business] in this County.

5. FACTUAL ALLEGATIONS

A. The Product

5.1. The Product at issue is [PRODUCT NAME / MODEL / DESCRIPTION; for a drug or device: drug/device name, NDC or model number, lot] (the "Product").

5.2. The Product was designed, manufactured, labeled, marketed, distributed, and/or sold by Defendants and reached Plaintiff without substantial change in the condition in which it was sold.

B. The Risk and the Inadequate or Absent Warning

5.3. The Product posed a risk of [DESCRIBE RISK / HAZARD] when used in its intended or reasonably foreseeable manner.

5.4. Defendants knew or, in light of the state of the art, should have known of the risk because: [pre-market testing; adverse-event/post-market surveillance; scientific literature; consumer complaints; regulatory communications; other — [____]].

5.5. The risk was not open and obvious to an ordinary consumer exercising reasonable care.

5.6. Defendants failed to provide any warning of the risk, or the warnings and instructions actually provided were inadequate because they [failed to describe the nature/severity of the risk; failed to describe how to avoid it; were not reasonably prominent or legible; used unclear or technical language; were not updated after the risk became known — [____]].

5.7. An adequate warning should have stated, in substance: [____].

C. Plaintiff's Use and Injury

5.8. On or about [__/__/____], Plaintiff [purchased / was prescribed / used] the Product in a manner that was intended and reasonably foreseeable.

5.9. On or about [__/__/____], as a direct and proximate result of the absent or inadequate warning, Plaintiff sustained [INJURY DESCRIPTION], requiring medical treatment at [PROVIDER/HOSPITAL].

5.10. Plaintiff did not misuse, alter, or modify the Product. Had an adequate warning been provided, Plaintiff would have heeded it and avoided the injury.

6. FIRST CAUSE OF ACTION — STRICT PRODUCTS LIABILITY: FAILURE TO WARN

(Against All Defendants)

6.1. Plaintiff realleges and incorporates Paragraphs 1.1 through 5.10 as though fully set forth.

6.2. Defendants are manufacturers and/or sellers who placed the Product into the stream of commerce. The Product reached Plaintiff without substantial change in its condition.

6.3. The Product was in a defective condition and unreasonably dangerous when it left Defendants' control because Defendants failed to provide adequate warnings or instructions concerning the risk described above, such that the Product failed to perform as safely as an ordinary consumer would expect and/or its risks outweighed its benefits. Gosewisch v. American Honda Motor Co., 153 Ariz. 400, 737 P.2d 376 (1987).

6.4. The defective condition arising from the inadequate or absent warning was a proximate cause of Plaintiff's injuries.

6.5. As a direct and proximate result, Plaintiff has suffered damages in amounts to be proven at trial.

7. SECOND CAUSE OF ACTION — NEGLIGENT FAILURE TO WARN

(Against All Defendants)

7.1. Plaintiff realleges and incorporates Paragraphs 1.1 through 6.5 as though fully set forth.

7.2. Defendants owed Plaintiff and other foreseeable users a duty to exercise reasonable care to warn of risks they knew or, in the exercise of reasonable care, should have known about, and to test, monitor, and update those warnings.

7.3. Defendants breached that duty by failing to provide adequate warnings or instructions, as described above.

7.4. Defendants' negligence was a proximate cause of Plaintiff's injuries.

7.5. This negligence claim is not subject to the 12-year statute of repose under A.R.S. § 12-551, which by its terms excepts claims based upon the negligence of the manufacturer or seller. Plaintiff has suffered damages in amounts to be proven at trial.

8. THIRD CAUSE OF ACTION — BREACH OF IMPLIED WARRANTY OF MERCHANTABILITY

(Against All Defendants)

8.1. Plaintiff realleges and incorporates Paragraphs 1.1 through 7.5 as though fully set forth.

8.2. Pursuant to A.R.S. § 47-2314, Defendants impliedly warranted that the Product was merchantable and fit for the ordinary purposes for which such goods are used. A product distributed without adequate warnings is not merchantable.

8.3. The Product was not merchantable because it lacked adequate warnings, and that breach proximately caused Plaintiff's injuries. Plaintiff gave notice within a reasonable time after discovery, or is excused from doing so.

8.4. As a direct and proximate result, Plaintiff has suffered damages in amounts to be proven at trial.

9. DAMAGES

9.1. Economic Damages. Past and future medical, hospital, rehabilitative, and pharmaceutical expenses; past and future lost earnings and loss of earning capacity; and out-of-pocket expenses, in amounts to be proven at trial.

9.2. Non-Economic Damages. Past and future physical pain and suffering, mental anguish, loss of enjoyment of life, disfigurement, and permanent impairment or disability, in amounts to be proven at trial. Arizona imposes no statutory cap on compensatory damages; Ariz. Const. art. II, § 31 prohibits caps on damages for death or personal injury.

9.3. Punitive Damages. Plaintiff seeks punitive damages on grounds that Defendants acted with an evil mind — consciously disregarding a substantial risk of significant harm — proven by clear and convincing evidence.

10. PRAYER FOR RELIEF

WHEREFORE, Plaintiff demands judgment against Defendants as follows:

• A. Compensatory damages according to proof;
• B. Punitive damages as permitted by law;
• C. Prejudgment and post-judgment interest as allowed by law;
• D. Taxable costs of suit; and
• E. Such other and further relief as the Court deems just and proper.

11. DEMAND FOR JURY TRIAL

Plaintiff demands a trial by jury on all issues so triable, pursuant to Ariz. Const. art. II, § 23 and Rule 38, Ariz. R. Civ. P.

12. SIGNATURE BLOCK

Date: [__/__/____]

Respectfully submitted,

[LAW FIRM NAME]

By: [____]

[ATTORNEY NAME], State Bar No. [______]

Counsel for Plaintiff

[STREET ADDRESS]

[CITY, STATE ZIP]

Telephone: [(___) ___-____]

Email: [EMAIL]

13. CERTIFICATE OF SERVICE

I certify that on [__/__/____], a true and correct copy of the foregoing was served upon all parties or their counsel of record by [the AZTurboCourt electronic-filing system / U.S. Mail / hand delivery] at the addresses below, in accordance with the Arizona Rules of Civil Procedure.

[NAME / ADDRESS OF EACH PARTY SERVED]

[____]

[NAME OF ATTORNEY / DECLARANT]

14. ARIZONA PRACTICE NOTES

• Statutory product-liability framework. A.R.S. § 12-681 et seq. governs. The definition of "product liability action" in § 12-681(5) expressly includes "the failure to warn or protect against a danger or hazard in the use or misuse of the product or the failure to provide proper instructions." Arizona recognizes both strict-liability and negligent warning theories.

• Strict-liability standard. Arizona uses consumer-expectation and risk-benefit analyses for defect (Gosewisch; Dart v. Wiebe Mfg.). For warning defects, the plaintiff shows the product was unreasonably dangerous because of inadequate warnings/instructions and that the inadequacy proximately caused the harm.

• Statutory defenses. A.R.S. § 12-683 codifies affirmative defenses including state of the art (the defect could not have been known given the technical/scientific knowledge available at the time of first sale), unforeseeable alteration/modification, and unforeseeable misuse. Anticipate these and plead foreseeable use.

• 12-year statute of repose — and its negligence exception. A.R.S. § 12-551 bars any product-liability action accruing more than 12 years after the product was first sold for use or consumption — EXCEPT actions based on the negligence of the manufacturer/seller or a breach of express warranty. This makes the negligent-failure-to-warn count strategically essential when the product is older than 12 years; plead negligence expressly and tie it to the § 12-551 exception.

• Statute of limitations. Two years from accrual under A.R.S. § 12-542; the discovery rule applies.

• Learned-intermediary doctrine. The Arizona Supreme Court adopted the learned-intermediary doctrine in Watts v. Medicis Pharmaceutical Corp., 239 Ariz. 19, 365 P.3d 944 (2016), rejecting the Court of Appeals' contrary view. A drug/device manufacturer satisfies its duty by giving complete, accurate, and appropriate warnings to the prescriber, with an exception where the manufacturer knows or has reason to know providers cannot reduce the risk per the instructions. Watts also held prescription drugs are "merchandise" under the Consumer Fraud Act, permitting a parallel CFA claim for affirmative misrepresentations.

• Pure comparative fault; several liability. A.R.S. § 12-2505 reduces damages by the claimant's proportionate fault without barring recovery; A.R.S. § 12-2506 generally abolishes joint liability and provides for several liability with allocation to non-parties (named via notice).

• Punitive damages. Arizona requires clear-and-convincing evidence of an "evil mind." No statutory cap, but constitutional due-process review applies.

• Federal preemption. Screen for MDA preemption of PMA Class III devices and generic-drug warning preemption.

15. SOURCES AND REFERENCES

• A.R.S. § 12-681 (definitions) — https://www.azleg.gov/ars/12/00681.htm
• A.R.S. § 12-551 (statute of repose) — https://www.azleg.gov/ars/12/00551.htm
• A.R.S. § 12-542 (two-year limitations); § 12-683 (defenses); § 12-2505 (comparative fault); § 12-2506 (several liability)
• Watts v. Medicis Pharmaceutical Corp., 239 Ariz. 19, 365 P.3d 944 (2016) — https://law.justia.com/cases/arizona/supreme-court/2016/cv-15-0065-pr.html
• Gosewisch v. American Honda Motor Co., 153 Ariz. 400, 737 P.2d 376 (1987)
• Dart v. Wiebe Manufacturing, Inc., 147 Ariz. 242, 709 P.2d 876 (1985)
• A.R.S. §§ 47-2314, 47-2315 (implied warranties)

Disclaimer: This template is provided for informational purposes only and does not constitute legal advice. An attorney licensed in Arizona must review and customize this document before filing. Laws, citations, and court rules change frequently; verify all authorities before use.